Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter now displays Revision: v3.3.4; the previous Revision: v3.3.3 is no longer displayed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a Locations section with state listings (Arizona, California, Hawaii, Indiana, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Washington) and updated the revision to v3.3.3. Some state location subsections were removed, and the HHS Vulnerability Disclosure notice was also removed.SummaryDifference0.8%

- Check60 days agoChange DetectedRevision: v3.3.2 added; Revision: v3.2.0 deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe government funding operating-status notice at the top of the page has been removed; this change does not modify study details or how to participate. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedThe screenshots show only cosmetic or navigation adjustments to the study page, with no modification to the study's essential content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check109 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.